Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 58.04% institutional investors, 4.04% insiders, and 37.91% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.40% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 58.04% | 4.04% | 37.91% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 11.54M | 7.40% | $53.87M |
| Blackrock | 10.33M | 7.35% | $23.25M |
| Vanguard group | 7.90M | 5.30% | $26.78M |
| State street | 3.26M | 2.32% | $7.33M |
| Geode capital management | 3.35M | 2.25% | $11.36M |
| Rosalind advisors | 3.10M | 2.08% | $10.53M |
| Qube research | 3.09M | 1.98% | $14.43M |
| Renaissance | 2.10M | 1.41% | $7.12M |
| Parkman healthcare partners | 2.11M | 1.35% | $9.84M |
| Driehaus capital management | 2.07M | 1.33% | $9.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 3.10M | 5.38% | $10.53M |
| Knott david m jr | 1.06M | 2.24% | $4.95M |
| Parkman healthcare partners | 2.11M | 1.13% | $9.84M |
| Stonepine capital management | 205.10K | 0.94% | $957.82K |
| Essex investment management | 474.95K | 0.29% | $1.61M |
| Redmile group | 451.10K | 0.22% | $2.11M |
| Options solutions | 132.99K | 0.18% | $621.08K |
| Entrypoint capital | 72.90K | 0.17% | $340.44K |
| Quarry lp | 162.50K | 0.16% | $758.88K |
| Alpine global management | 150.00K | 0.16% | $700.50K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 1.73M | 0.00% | 1.45M |
| Qube research | 3.09M | 0.01% | 1.25M |
| Goldman sachs group | 1.59M | 0.00% | 754.14K |
| Blackrock funding, inc. /de | 11.54M | 0.00% | 741.72K |
| Driehaus capital management | 2.07M | 0.08% | 659.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Centerbook partners lp | 690.08K | 0.14% | -2.79M |
| Aigh capital management | - | - | -2.57M |
| Caxton | - | - | -2.02M |
| Invenomic capital management lp | - | - | -592.08K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Essex investment management | 474.95K | 0.29% | 474.95K | $1.61M |
| Eam investors | 222.38K | 0.11% | 222.38K | $753.86K |
| Calamos advisors | 137.10K | 0.00% | 137.10K | $1.12M |
| Polen capital management | 132.99K | 0.00% | 132.99K | $621.08K |
| Campbell & co investment adviser | 132.38K | 0.04% | 132.38K | $618.22K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| American capital advisory | -50.00 |
| Stephens consulting | -65.00 |
| Soa wealth advisors, llc. | -118.00 |
| Comerica bank | -417.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 205 | - | 90,532,231 | 4.30% | 58 | 1.79% | 106 | -17.83% | 58 | 45.00% |
| Mar 31, 2025 | 204 | 24.39% | 86,739,126 | 32.43% | 56 | 2.94% | 129 | 46.59% | 39 | 14.71% |
| Dec 31, 2024 | 68 | -53.42% | 28,055,641 | -56.11% | 18 | 1.02% | 34 | -53.42% | 9 | -73.53% |
| Sep 30, 2024 | 143 | 4.38% | 63,815,802 | 5.21% | 42 | 2.30% | 71 | 1.43% | 34 | -5.56% |
| Jun 30, 2024 | 137 | -6.16% | 60,658,095 | 0.07% | 43 | 2.32% | 70 | -17.65% | 36 | 9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.80M | 2.97% | -106.27K |
| Vanguard US Total Market Shares ETF | 4.25M | 2.76% | - |
| iShares Russell 2000 ETF | 3.64M | 2.26% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.73M | 1.07% | -781.92K |
| CREF Stock R1 | 1.48M | 0.96% | - |
| Fidelity Small Cap Index | 1.50M | 0.93% | 82.40K |
| Nuveen Quant Small Cap Equity R6 | 1.38M | 0.85% | 199.60K |
| iShares Russell 2000 Growth ETF | 1.33M | 0.82% | - |
| CREF Stock R3 | 872.07K | 0.54% | 294.50K |
| Fidelity Extended Market Index | 867.45K | 0.54% | 9.33K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2025 | PERSKY MARLA | - | Sell | $119.61K |
| Aug 28, 2025 | SHERMAN JEFFREY W | - | Sell | $334.52K |
| Aug 13, 2025 | JOHNSON JOHN | - | Sell | $786.46K |
| Aug 12, 2025 | HALKUFF DAWN | - | Sell | $309.23K |
| Jun 13, 2025 | McCulloch Kevin | See Remarks | Buy | $109.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | 4 |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | - |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools